TB
Trellis Bioscience, Inc.
SEC filingBiotechnology · Redwood City, CA
Amount raised$6.1Msold at filing
Total offeringNot stated
Investors in the raise16count reported to the SEC
FiledMay 15, 2026first sale Jan 30, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Stefan RyserExecutive Officer
Geoff DillonExecutive Officer
Larry KauvarExecutive Officer
Elisabeth WhitneyExecutive Officer
Nora MendeExecutive Officer
Executive officers, directors and promoters as listed on the Form D.